GMGerald Mutungi

Gerald Mutungi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gerald Mutungi has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    OA-317 A multi-component integrated HIV/HTN care model improves hypertension screening and control in rural Uganda: a cluster randomized trial

    by Jane Kabami, Mucunguzi Atukunda, Gerald Mutungi, Brian Twinamatsiko, Justus Tumusiime, Michael Ayebare, Cecilia Akatukwasa, Alan Asiimwe, Elizabeth Arinitwe, Joana Nangendo, et al.

    Background The prevalence of hypertension (HTN) is increasing among people with HIV (PHIV) across sub-Saharan Africa. However, little data exist on the effectiveness of integrated HIV and HTN care delivery systems on blood pressure [BP] screening and control. Methods We conducted a cluster-randomized trial among PHIV (≥18 years) to evaluate a multicomponent integrated HIV/HTN care model (intervention) versus standard-of-care (control) in 52 health centres (HCs, 2/district and 26/arm) in rural Southwestern Uganda (NCT04624061), with districts as unit of randomization. The intervention included: 1) health worker training on integrating HTN care, 2) promoting HTN screening and care; 3) introduction/improvement of NCD registers, patient care cards, and HTN data capture in electronic medical records; 4) WhatsApp messages for coordination among providers and district health teams. Both arms received BP machines, NCD registers, patient cards, and buffer HTN medicines. Evaluation included: cross-sectional surveys administered annually to a random sample of patients in each HC. Primary endpoints were recent HTN screening and HTN control (<= 140/90 mm Hg) at 24-months. We examined differences in screening (intervention vs. control) within subgroups and change in HTN control (BPResults Among 3,603 PHIV (2,114 intervention; 1,489 control; 53% women; 47% aged ≤40years) surveyed at 24-months, HTN screening was 76% in intervention vs. 22% in control clinics; risk ratio (RR)=3.44 (95%CI:2.50–4.72; pConclusion The integrated HIV/HTN care model dramatically improved overall HTN screening and BP control among PHIV and HTN. This presents opportunities to reduce NCD related morbidity and mortality and improve HIV/HTN care.

  • Open Access

    Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa: Field notes from Uganda

    by Faith Moyo, Josephine Birungi, Anupam Garrib, Ivan Namakoola, Joseph Okebe, Sokoine Kivuyo, Gerald Mutungi, Sayoki Mfinanga, Moffat Nyirenda, Shabbar Jaffar

    Integration of HIV and non-communicable disease (NCD) services is proposed to increase efficiency and coverage of NCD care in sub-Saharan Africa. Between October 2018 to January 2020 in Tanzania and Uganda, working in partnership with health services, we introduced an integrated chronic care model for people with HIV, diabetes and hypertension. In this model, patients were able to access care from a single point of care, as opposed to the standard of siloed care from vertical clinics. When the study ended, routine clinical services adopted the integrated model. In this article, we discuss how the model transitioned post hand-over in Uganda and draw lessons to inform future scale-up. The findings suggest potential for successful uptake of integrated chronic care by routine clinical services in sub-Saharan Africa. This approach may appeal to health care service providers and policy makers when they can quantify benefits that accrue from it, such as optimal utilization of health resources. For patients, integrated care may not appeal to all patients due to HIV-related stigma. Key considerations include good communication with patients, strong leadership, maintaining patient confidentiality and incorporating patient needs to facilitate successful uptake. Evidence on the benefits of integrated care remains limited. More robust evidence will be essential to guide scale-up beyond research sites.


  • Open Access

    ‘Implementability’ matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries

    by Angela Mary Jackson-Morris, Gerald Mutungi, Ephantus Maree, Temo Waqanivalu, Robert Marten, Rachel Nugent

    The ‘implementation gap’ between national plans and successful implementation is a central theme in addressing non-communicable diseases (NCDs). It is a factor that has undermined Sustainable Development Goal 3.4, which aims to achieve a one-third reduction in premature mortality from four major NCDs by 2030. Responding to the potential of implementation research to support low-income and middle-income countries to effectively advance their strategies, we describe ways to make NCD plans more robust by including implementation steps. These steps are (1) choosing some (but not all) effective and cost-effective options; (2) tailoring interventions and their scale-up to national capacity; and (3) making the priorities implementable. We illustrate with examples from several countries.


  • Open Access

    Screening tuberculosis patients for diabetes mellitus in a routine program setting in Kampala, Uganda: a cross-sectional study

    by Joseph Nsonga, John Paul Dongo, Frank Mugabe, Gerald Mutungi, Richard Walyomo, Christopher Oundo, Sarah Zalwango, Daniel Okello, Simon Muchuro, Riitta A Dlodlo, et al.

    Background : Uganda is located in East Africa and is among the countries with the lowest income globally. The ten health centres in this project serve populations in the under-privileged communities of Kampala. The objective of the study was to implement diabetes mellitus (DM) screening among tuberculosis (TB) patients in a routine program setting with limited resources and high human immunodeficiency virus (HIV) prevalence. Methods : A descriptive cross-sectional observational study was conducted in ten health centres in Kampala, Uganda. As part of a project to implement DM screening in a routine setting, TB patients were screened for DM by trained health workers. A fasting blood glucose (FBG) value ≥7.0mmol/l was considered to indicate DM. For this study, aggregate data was collected and analysed using SPSS for Windows, version 13.0. Results : Among 4,590 TB patients registered, 4,016 (88.0%) were screened with random blood glucose (RBG). Of those with RBG ≥6.1mmol/l, 1,093 (83.3%) were screened with FBG. In total, 92 (2.3%) patients were diagnosed with DM and 66 (71.8%) of them were newly diagnosed. The proportion of TB patients screened with FBG in the health centres varied from 58.2% to 100%. The proportion of patients screened with FBG and the prevalence of DM were significantly higher in private health centres compared with public health centres. The health centres in peri-urban areas screened more patients with RBG than those in urban areas. Health centres without DM services screened a larger number of patients with RBG and FBG than those with DM services. Conclusions : It appears feasible to implement screening TB patients for DM in routine program settings with limited resources and high HIV prevalence. Its introduction requires close collaboration between TB and DM services. The challenges identified need government attention and certain institutional and service-related factors need to be better managed at times.